PGHL — Procter & Gamble Health Balance Sheet
0.000.00%
- IN₹103.65bn
- IN₹101.73bn
- IN₹9.34bn
- 82
- 13
- 96
- 74
Annual balance sheet for Procter & Gamble Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,689 | 3,269 | 4,476 | 2,519 | 1,821 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,376 | 1,579 | 2,012 | 1,451 | 2,221 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,271 | 6,080 | 7,961 | 5,242 | 5,264 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,400 | 1,496 | 1,733 | 1,315 | 1,220 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 9,862 | 8,881 | 11,012 | 7,944 | 7,942 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,390 | 2,319 | 3,039 | 2,189 | 2,153 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,825 | 2,716 | 3,503 | 2,561 | 2,572 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 7,037 | 6,165 | 7,509 | 5,382 | 5,370 |
Total Liabilities & Shareholders' Equity | 9,862 | 8,881 | 11,012 | 7,944 | 7,942 |
Total Common Shares Outstanding |